Company

AFT Pharmaceuticals Limited

Headquarters: Auckland, New Zealand

Employees: 94

CEO: Dr. Hartley Atkinson Ph.D.

ASX: AFP +3.26%

Market Cap

A$307.4 Million

AUD as of July 1, 2024

US$204.7 Million

Market Cap History

AFT Pharmaceuticals Limited market capitalization over time

Evolution of AFT Pharmaceuticals Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of AFT Pharmaceuticals Limited

Detailed Description

AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail and oral care, pain management, skin care, and other products, as well as supplements. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

AFT Pharmaceuticals Limited has the following listings and related stock indices.


Stock: ASX: AFP wb_incandescent

Details

Headquarters:

129 Hurstmere Road

Level 1 Takapuna

Auckland, 0622

New Zealand

Phone: 64 9 488 0232

Fax: 800 423 874